On Invalid Date, Oncolytics Biotech (NASDAQ: ONCY) reported Q3 2023 earnings per share (EPS) of -$0.10, up 70.49% year over year. Total Oncolytics Biotech earnings for the quarter were -$7.35 million. In the same quarter last year, Oncolytics Biotech's earnings per share (EPS) was -$0.06.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.